LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $368,000 | -69.2% | 3,700 | -64.7% | 0.00% | -72.7% |
| Q2 2019 | $1,196,000 | +16.0% | 10,480 | +27.8% | 0.01% | +22.2% |
| Q1 2019 | $1,031,000 | +346.3% | 8,200 | +382.4% | 0.01% | +350.0% |
| Q4 2018 | $231,000 | -96.5% | 1,700 | -92.9% | 0.00% | -94.4% |
| Q3 2018 | $6,561,000 | +156.7% | 23,900 | +93.6% | 0.04% | +176.9% |
| Q2 2018 | $2,556,000 | +778.4% | 12,342 | +601.2% | 0.01% | +550.0% |
| Q1 2018 | $291,000 | -56.4% | 1,760 | -72.1% | 0.00% | -66.7% |
| Q1 2017 | $667,000 | -69.0% | 6,303 | -70.2% | 0.01% | -66.7% |
| Q4 2016 | $2,149,000 | +29.2% | 21,147 | +29.7% | 0.02% | +20.0% |
| Q3 2016 | $1,663,000 | +200.2% | 16,299 | +250.7% | 0.02% | +200.0% |
| Q2 2016 | $554,000 | +66.4% | 4,647 | +40.8% | 0.01% | +25.0% |
| Q2 2015 | $333,000 | -70.2% | 3,300 | -86.1% | 0.00% | -69.2% |
| Q3 2014 | $1,118,000 | – | 23,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |